David Cameron

14PUBLICATIONS

177CO-AUTHORS

Phylogeny and comparative analysisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological methods

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 12, 2026

Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT.

|Dec 22, 2025

Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).

Chiara Biagioni, Danai Fimereli, Alexandre Irrthum

|Oct 08, 2025

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.

Shanu Modi, William Jacot, Hiroji Iwata

|Oct 18, 2024

Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis.

Per Karlsson, Anthony Fyles, S Laura Chang

|Feb 01, 2024

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Patricia A Ganz, Hanna Bandos, Tanja Španić

|Nov 08, 2023

Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7.

Aleix Prat, Nadia Solovieff, Fabrice André

Pageof 3

Frequent Collaborators

Richard Gelber

Martine Piccart

Sylvie Giacchetti

Andreas Schneeweiss

Everardo D Saad

Luca Gianni

Michael Untch

Sibylle Loibl

Fabrice André

Aleix Prat

Frequent Collaborators

Richard Gelber

Martine Piccart

Sylvie Giacchetti

Andreas Schneeweiss